EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biofilm Lifestyle in Recurrent Urinary Tract Infections

Amr S Abu Lila iD, Azza A H Rajab, Marwa H Abdallah iD, Syed Mohd Danish Rizvi iD, Afrasim Moin iD, El-Sayed Khafagy iD, Shams Tabrez iD, Wael A H Hegazy iD

Life · 04.01.2023 · 13 (1) · 148

DOI: 10.3390/life13010148 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 04.01.2023. Verfasst von Amr S Abu Lila und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il 81442, Saudi Arabia. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 262 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Deanship at the University of Ha’il, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary tract infections (UTIs) represent one of the most common infections that are frequently encountered in health care facilities. One of the main mechanisms used by bacteria that allows them to survive hostile environments is biofilm formation. Biofilms are closed bacterial communities that offer protection and safe hiding, allowing bacteria to evade host defenses and hide from the reach of antibiotics. Inside biofilm communities, bacteria show an increased rate of horizontal gene transfer and exchange of resistance and virulence genes. Additionally, bacterial communication within the biofilm allows them to orchestrate the expression of virulence genes, which further cements the infestation and increases the invasiveness of the infection. These facts stress the necessity of continuously updating our information and understanding of the etiology, pathogenesis, and eradication methods of this growing public health concern. This review seeks to understand the role of biofilm formation in recurrent urinary tact infections by outlining the mechanisms underlying biofilm formation in different uropathogens, in addition to shedding light on some biofilm eradication strategies.

Schlagwörter

Stichwörter der Autor:innen

anti-virulence agentsbiofilm eradicationbiofilm formationcatheter-associated urinary tract infectionsrecurrent urinary tract infections

Autor:innen und Institutionen

  • Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il 81442, Saudi Arabia.
  • Molecular Diagnostics and Personalized Therapeutics Unit, University of Ha'il, Ha'il 81442, Saudi Arabia.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
  • Department of Pharmaceutics, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.

ORCID-Profile: Amr S Abu Lila, Marwa H Abdallah, Syed Mohd Danish Rizvi, Afrasim Moin, El-Sayed Khafagy, Shams Tabrez, Wael A H Hegazy

Förderung

  • Scientific Research Deanship at the University of Ha’il, Saudi Arabia

Zitieren

APA

Lila, A. S. A., Rajab, A. A. H., Abdallah, M. H., Rizvi, S. M. D., Moin, A., Khafagy, E. S., Tabrez, S., & Hegazy, W. A. H. (2023). Biofilm Lifestyle in Recurrent Urinary Tract Infections. Life, 13(1), 148. https://doi.org/10.3390/life13010148

Vancouver

Lila ASA, Rajab AAH, Abdallah MH, Rizvi SMD, Moin A, Khafagy ES, et al. Biofilm Lifestyle in Recurrent Urinary Tract Infections. Life. 2023;13(1):148. doi:10.3390/life13010148

BibTeX
@article{Lila2023,
  author = {Lila, Amr S Abu and Rajab, Azza A H and Abdallah, Marwa H and Rizvi, Syed Mohd Danish and Moin, Afrasim and Khafagy, El-Sayed and Tabrez, Shams and Hegazy, Wael A H},
  title = {Biofilm Lifestyle in Recurrent Urinary Tract Infections},
  journal = {Life},
  year = {2023},
  volume = {13},
  number = {1},
  pages = {148},
  doi = {10.3390/life13010148}
}
Kostenlos starten →